PARIS (Reuters) – Healthcare group Novacyt announced more progress on Monday on plans to roll out its coronavirus test product, winning a new order in India and getting regulatory approval in Argentina.
Novacyt said that as of March 27, the group’s ‘Primerdesign’ product aimed at testing for the coronavirus had sold and received orders worth more than 17.8 million pounds ($22 million).
It added that it was now selling its coronavirus test product to more than 80 countries, with the Middle East becoming the strongest selling region.
(Reporting by Sudip Kar-Gupta, editing by Louise Heavens)
